CCL5 and melanoma: Silencing PGC1-beta expression increased galectin-9 levels, and CCL5 secretion in human melanoma cells78, suggesting that the mitochondrial biogenesis pathway in melanoma can also modulate the immunosuppressive cancer cell phenotype.